Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA

Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA

Related Keywords

Australia ,Germany ,London ,City Of ,United Kingdom ,Ibrahim Khalil ,Sarah Macleod ,Arix Bioscience ,John Quisel ,Robert Lyne ,Nick Johnson ,Powerscourt Group ,European Haematology Association ,Nasdaq ,European Hematology Association ,Disc Medicine Press ,Disc Medicine Inc ,Disc Medicine ,Medicine Press Release ,Presents Positive Initial Data ,Erythropoietic Protoporphyria ,Chief Executive Officer ,Will Savage ,Chief Medical Officer ,Global Impression ,X Linked Protoporphyria ,